Evidence map›Paper›PMID 39210013›Full record

ArticleScientific reports2024

Neutrophil-specific interactome of ARHGAP25 reveals novel partners and regulatory insights.

Péter Sasvári, Aladár Pettkó-Szandtner, Éva Wisniewski, Roland Csépányi-Kömi

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Péter SasváriDepartment of Physiology, Semmelweis University, Tűzoltó u. 37-47., Budapest, 1085, Hungary.
Aladár Pettkó-SzandtnerProteomics Research Group, Core Facility, HUN-REN Biological Research Centre, Szeged, 6726, Hungary.
Éva WisniewskiDepartment of Physiology, Semmelweis University, Tűzoltó u. 37-47., Budapest, 1085, Hungary.
Roland Csépányi-KömiDepartment of Physiology, Semmelweis University, Tűzoltó u. 37-47., Budapest, 1085, Hungary. csepanyi-komi.roland@semmelweis.hu.

Funding

EU Horizon 2020 739593GINOP GINOP-2.3.2-15-2016-00001National Research, Development and Innovation Office FK_18 128376Nemzeti Kutatási, Fejlesztési és Innovaciós Alap KIM NKFIA 2022-2.1.1-NL-2022-00005Nemzeti Kutatási, Fejlesztési és Innovaciós Alap TKP2021-EGA-24
6 · The paper itself

Abstract

ARHGAP25, a crucial molecule in immunological processes, serves as a Rac-specific GTPase-activating protein. Its role in cell migration and phagocyte functions, affecting the outcome of complex immunological diseases such as rheumatoid arthritis, renders it a promising target for drug research. Despite its importance, our knowledge of its intracellular interactions is still limited. This study employed proteomic analysis of glutathione S-transferase (GST)-tag pulldowns and co-immunoprecipitation from neutrophilic granulocyte cell lysate, revealing 76 candidates for potential physical interactions that complement ARHGAP25's known profile. Notably, four small GTPases (RAC2, RHOG, ARF4, and RAB27A) exhibited high affinity for ARHGAP25. The ARHGAP25-RAC2 and ARHGAP25-RHOG interactions appeared to be affected by the activation state of the small GTPases, suggesting a GTP-GDP cycle-dependent interaction. In silico dimer prediction pinpointed ARHGAP25's GAP domain as a credible binding interface, suggesting its suitability for GTP hydrolysis. Additionally, a list of Fc receptor-related kinases, phosphatases, and three of the 14-3-3 members were identified as potential partners, with in silico predictions highlighting eight binding sites, presenting novel insight on a potential regulatory mechanism for ARHGAP25.

Indexed as

GTPase-Activating ProteinsNeutrophilsProtein Binding14-3-3 ProteinsHumansProteomicsRAC2 GTP-Binding Proteinrho GTP-Binding Proteins14-3-3 ProteinsGTPase-Activating ProteinsRAC2 GTP-Binding Proteinrho GTP-Binding Proteins14-3-3 ProteinsARHGAP25Protein–protein interactionsRAC2RHOG

Identifiers

PMID39210013
PMCPMC11362597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.